| Print
Vicore Pharma Holding AB (VICO)
1This share can be held in a Dealing accountSIPP
Company profile
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| Vicore Pharma Holding AB Annual Report for 2026 | 2027-03-26T00:00:00 |
| Vicore Pharma Holding AB Fourth Quarter Earnings Results for 2026 | 2027-02-25T00:00:00 |
| Vicore Pharma Holding AB Third Quarter Earnings Results for 2026 | 2026-11-05T00:00:00 |
| Vicore Pharma Holding AB Second Quarter Earnings Results for 2026 | 2026-08-21T00:00:00 |
| Vicore Pharma Holding AB Annual General Meeting for 2026 | 2026-05-06T15:00:00 |
| Vicore Pharma Holding AB First Quarter Earnings Results for 2026 | 2026-05-06T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Vicore Pharma Holding AB Annual Report for 2025 | 2026-03-26T00:00:00 |
| Vicore Pharma Holding AB Fourth Quarter Earnings Results for 2025 | 2026-02-27T00:00:00 |
| Vicore Pharma Holding AB Third Quarter Earnings Results for 2025 | 2025-11-05T00:00:00 |
| Vicore Pharma Holding AB Second Quarter Earnings Results for 2025 | 2025-08-22T00:00:00 |
| Vicore Pharma Holding AB Annual General Meeting for 2025 | 2025-05-06T15:00:00 |
| Vicore Pharma Holding AB First Quarter Earnings Results for 2025 | 2025-05-06T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.